Status
Conditions
Treatments
About
To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making
Full description
In a double-blind, between- subject placebo (PLC) controlled design, subjects will first complete a series of questionnaires in terms of mood, clinical symptoms, and traits. After that their moral judgment and emotion towards both verbal descriptions of moral dilemma scenarios and pictures of specific interpersonal ones will be assessed and the effect of intranasal OXT and AVP between both male and female healthy subjects will be investigated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
180 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Keith M. Kendrick, Dr.; Benjamin Becker, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal